Table 2.
Outcomes of other instruments assessed in single RCTs.
| Study | Comparison | Instrument/outcome | Finding |
|---|---|---|---|
| Blumberger 20181 | rTMS vs. TBS | IDS-30; response ≥50% from baseline | TBS non-inferior to HFL rTMS |
| Blumberger 20181 | rTMS vs. TBS | QIDS-SR; response ≥50% from baseline | TBS non-inferior to HFL rTMS |
| Blumberger 20181 | rTMS vs. TBS | BSI-A; response ≥50% from baseline | TBS non-inferior to HFL rTMS |
| Blumberger 20181 | rTMS vs. TBS | IDS-30; remission <14 | TBS non-inferior to HFL rTMS |
| Blumberger 20181 | rTMS vs. TBS | QIDS-SR; remission <6 | TBS non-inferior to rTMS |
| Desmyter 201412 | TBS vs. sham | BSI score | P < 0.01 favoring TBS |
| Plewnia 201417 | TBS vs. sham | MARDS ≤ 50% from baseline; response | P = 0.048 favoring TBS |
| Mielacher 201916 | Once vs. twice daily TBS | HRSD percent reduction | P = 0.043 favoring twice daily TBS |
BSI Beck Scale for Suicide Ideation (Beck & Steer 1991), BSI-A Brief Symptom Inventory-Anxiety subscale (BSI; Derogatis & Melisaratos, 1983); IDS-3 Inventory for Depressive Symptomatology, 30-item (Rush et al. 1996); MADRS Montgomery-Åsberg, Depression Rating Scale (Montgomery & Asberg 1979); QIDS-SR = 16 item Quick Inventory of Depressive Symptomatology (Self-Report version) (Rush et al. 2003).